Strategic competitor analysis for gene therapy markets

May 26, 2026

The challenge

A prominent pharmaceutical company aiming to advance gene therapies was seeking to enhance its market position in the treatment of a rare disease. The pharma company needed to navigate competitive dynamics and assess the market potential for their developing gene therapy, with a focus on key global markets including North America and Europe. They sought insights into competitor strategies, regulatory hurdles, and market access challenges to inform their market entry strategy effectively.

    The Acumetis approach

    Acumetis insights & analytics partnered with the client to conduct a comprehensive competitor analysis focused on the evolving gene therapy landscape, market dynamics, and long-term market entry considerations, leveraging the Acumetis proprietary market data tracking platform to monitor competitor activities, product pipelines, and strategic market movements.

    Competitive landscape assessment

    Our team employed its market tracking platform to rigorously monitor competitor activities, product pipelines, and market strategies across the evolving gene therapy landscape.

    Market access and adoption analysis

    Acumetis conducted a comprehensive market access analysis, identifying regulatory and reimbursement factors impacting gene therapy adoption across targeted regions.

    Strategic forecasting and market insight development

    Using these findings, the team developed strategic forecasts to predict market trends and competitor movements, enabling more informed decision-making and long-term market planning.

    insights cs gene therapy

    The outcome

    The engagement provided the client with a clearer understanding of the competitive gene therapy landscape, emerging market dynamics, and factors influencing future adoption. By connecting competitive intelligence, market access considerations, and strategic forecasting, the organization strengthened its ability to refine positioning, anticipate competitor movements, and support more informed market entry and commercialization decisions.

    Why it worked

    • Empowered the client to strategically position its gene therapy within an evolving and competitive market landscape.
    • Supported optimization of market entry strategies through integrated competitive intelligence and strategic forecasting.
    • Identified potential partnership opportunities to strengthen long-term commercialization planning and market positioning.
    • Leveraged insights from the Acumetis market tracking platform to support more informed decision-making and competitor monitoring.
    • Equipped the client to navigate complex regulatory and reimbursement landscapes while capitalizing on emerging market opportunities.

    Acumetis insights and analytics team

    Rare and specialty markets require granular insight and expert interpretation to uncover the hidden insights that others can’t see. Our proprietary information platforms deliver patient-level granularity across rare and specialty indications creating transparency in markets that are otherwise opaque. But data alone doesn’t drive strategy. Our senior experts translate those signals into clear, defensible recommendations that sharpen decisions across medical, access, and commercial teams. The result: a clearer picture of what’s happening in your market, smarter prioritization of where to act, and decisions your team can stand behind. Meet with our experts to learn more about our team.

      To learn how Acumetis insights & analytics can support your competitive intelligence and strategic market planning, contact us to start the conversation.

      Request a Consultation

      Our experts can help you reframe what’s possible. 

      Let's Talk

      "*" indicates required fields

      Learn More

      Meet the Experts:

      Maik Klasen
      Maik Klasen
      Senior Partner, Insights and Analytics Practice Lead

      Maik Klasen was one of the founding Managing Directors of Adivo Associates, now part of Acumetis. He began his career as an immunologist and geneticist at UCSF before moving into the biotech startup world through two California-based companies that were later acquired. Prior to founding Adivo Associates, now part of Acumetis, Maik led Frost & Sullivan’s Global Healthcare and Life Sciences Consulting Practice, managing engagements across pharmaceutical, biotechnology, medical device, diagnostics, and healthcare IT companies. He continues to serve on the boards of multiple biopharma organizations, combining perspectives as both entrepreneur and strategy consultant.

      FAQs on competitor analysis for gene therapy

      1. How does competitor analysis support gene therapy commercialization?

      Competitor analysis helps organizations understand market dynamics, pipeline activity, treatment trends, and differentiation opportunities to support stronger commercialization and market entry strategies.

      2. Why is market access analysis important in gene therapy?

      Market access analysis helps identify regulatory, reimbursement, and adoption factors that can impact the success of gene therapies across different markets and healthcare systems.

      3. How can strategic forecasting improve market planning?

      Strategic forecasting helps organizations anticipate competitor movements, evolving market trends, and future opportunities, enabling more informed long-term planning and positioning decisions.